• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据国际协议对Microlife WatchBP Home设备进行家庭自测血压的验证。

Validation of the Microlife WatchBP Home device for self home blood pressure measurement according to the International Protocol.

作者信息

Stergiou George S, Giovas Periklis P, Gkinos Charilaos P, Patouras John D

机构信息

Hypertension Center, Third University Department of Medicine, Sotiria Hospital, Athens, Greece.

出版信息

Blood Press Monit. 2007 Jun;12(3):185-8. doi: 10.1097/MBP.0b013e3280b083ce.

DOI:10.1097/MBP.0b013e3280b083ce
PMID:17496469
Abstract

OBJECTIVE

Current guidelines recommend that self monitoring of blood pressure at home should only be performed using validated devices. This study assessed the accuracy of the Microlife WatchBP Home device for self home blood pressure measurement according to the European Society of Hypertension International Protocol.

METHODS

Thirty-three participants were included (15 in phase 1 and an additional 18 in phase 2). Simultaneous blood pressure measurements were taken by two observers (Y-tube-connected mercury sphygmomanometers) four times sequentially, with three measurements taken using the tested device. Absolute differences between observer and device measurements were classified into three zones (within 5, 10 and 15 mmHg). The number of measurements with a difference within 5 mmHg was calculated for each individual.

RESULTS

In phase 1, the device produced 38, 43 and 43 measurements within 5, 10 and 15 mmHg, respectively, for systolic blood pressure and 35, 45 and 45 for diastolic blood pressure. In phase 2.1, the device produced 75, 91 and 97 measurements within 5, 10 and 15 mmHg for systolic, and 74, 93 and 99 for diastolic blood pressure. In phase 2.2, 30 participants had at least two of their differences within 5 mmHg and two participants had no differences within 5 mmHg for systolic blood pressure, whereas for diastolic blood pressure the number of participants were 27 and three, respectively. Mean difference for systolic blood pressure was -0.3+/-5.6 mmHg and for diastolic -2.4+/-4.8 mmHg.

CONCLUSIONS

The Microlife WatchBP Home device for self home blood pressure measurement fulfills all the validation criteria of the International Protocol and can, therefore, be recommended for clinical use in the adult population.

摘要

目的

当前指南建议,家庭自测血压应仅使用经过验证的设备进行。本研究根据欧洲高血压学会国际协议评估了Microlife WatchBP Home设备用于家庭自测血压的准确性。

方法

纳入33名参与者(第1阶段15名,第2阶段额外18名)。两名观察者(使用Y形管连接的汞柱式血压计)依次进行4次同步血压测量,同时使用测试设备进行3次测量。将观察者与设备测量值之间的绝对差值分为三个区域(5 mmHg以内、10 mmHg以内和15 mmHg以内)。计算每个个体差值在5 mmHg以内的测量次数。

结果

在第1阶段,该设备收缩压在5 mmHg以内、10 mmHg以内和15 mmHg以内的测量次数分别为38次、43次和43次,舒张压分别为35次、45次和45次。在第2.1阶段,该设备收缩压在5 mmHg以内

相似文献

1
Validation of the Microlife WatchBP Home device for self home blood pressure measurement according to the International Protocol.根据国际协议对Microlife WatchBP Home设备进行家庭自测血压的验证。
Blood Press Monit. 2007 Jun;12(3):185-8. doi: 10.1097/MBP.0b013e3280b083ce.
2
Validation of the Microlife BPA100 Plus device for self-home blood pressure measurement according to the International Protocol.根据国际协议对Microlife BPA100 Plus设备进行家庭自测血压的验证。
Blood Press Monit. 2006 Jun;11(3):157-60. doi: 10.1097/01.mbp.0000209071.84965.bf.
3
Validation of the OMRON M7 (HEM-780-E) blood pressure measuring device in a population requiring large cuff use according to the International Protocol of the European Society of Hypertension.根据欧洲高血压学会国际协议,对欧姆龙M7(HEM-780-E)血压测量设备在需要使用大尺寸袖带的人群中的验证。
Blood Press Monit. 2007 Jun;12(3):173-8. doi: 10.1097/MBP.0b013e3280b08367.
4
Trial of validation of two devices for self-measurement of blood pressure according to the European Society of Hypertension International Protocol: the Citizen CH-432B and the Citizen CH-656C.根据欧洲高血压学会国际协议对两款自动测量血压设备(西铁城CH-432B和西铁城CH-656C)进行验证的试验。
Blood Press Monit. 2008 Feb;13(1):55-62. doi: 10.1097/MBP.0b013e3282cb599a.
5
Validation of two automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension: the Omron M6 (HEM-7001-E) and the Omron R7 (HEM 637-IT).根据欧洲高血压学会国际协议对两种自动血压自测设备进行验证:欧姆龙M6(HEM-7001-E)和欧姆龙R7(HEM 637-IT)。
Blood Press Monit. 2006 Jun;11(3):165-71. doi: 10.1097/01.mbp.0000209078.17246.34.
6
Validation of the Microlife WatchBP O3 device for clinic, home, and ambulatory blood pressure measurement, according to the International Protocol.根据国际协议对Microlife WatchBP O3设备进行诊所、家庭和动态血压测量的验证。
Blood Press Monit. 2010 Feb;15(1):59-62. doi: 10.1097/MBP.0b013e32833531ca.
7
Validation of the Microlife Watch BP Office professional device for office blood pressure measurement according to the International protocol.根据国际协议对Microlife Watch BP Office专业设备进行办公室血压测量的验证。
Blood Press Monit. 2008 Oct;13(5):299-303. doi: 10.1097/MBP.0b013e3283057af6.
8
Validation of the Samsung SBM-100A and Microlife BP 3BU1-5 wrist blood pressure measuring devices in adults according to the International Protocol.按照国际协议对三星SBM - 100A和迈克大夫BP 3BU1 - 5腕式血压测量设备在成人中的验证。
Blood Press Monit. 2007 Apr;12(2):119-25. doi: 10.1097/MBP.0b013e3280b08355.
9
Validation of the Oregon scientific BPW810 blood pressure monitor according to the European Society of Hypertension Protocol.根据欧洲高血压学会协议对俄勒冈科学BPW810血压监测仪进行验证。
Blood Press Monit. 2006 Dec;11(6):343-7. doi: 10.1097/01.mbp.0000217994.30141.f2.
10
Validation of the Artsana CSI 610 automated blood pressure monitor in adults according to the International Protocol of the European Society of Hypertension.根据欧洲高血压学会国际协议对成人使用的阿萨纳CSI 610自动血压监测仪进行验证。
Blood Press Monit. 2007 Jun;12(3):179-84. doi: 10.1097/MBP.0b013e3280b08394.

引用本文的文献

1
The HOME (home monitoring of high-risk pregnancies) study: a study protocol for an observational study of a telemedicine-assisted follow-up at home vs. hospitalization.HOME(高危妊娠家庭监测)研究:一项关于远程医疗辅助家庭随访与住院治疗的观察性研究方案。
Front Glob Womens Health. 2025 Jul 14;6:1599153. doi: 10.3389/fgwh.2025.1599153. eCollection 2025.
2
Optimal nighttime blood pressure monitoring schedule using home monitors in children and adolescents: association with ambulatory blood pressure and preclinical target-organ damage.使用家用监测仪对儿童和青少年进行最佳夜间血压监测方案:与动态血压及临床前期靶器官损害的关联
Hypertens Res. 2025 May 23. doi: 10.1038/s41440-025-02238-4.
3
Home versus routine dialysis-unit blood pressure recordings among patients on hemodialysis.
血液透析患者家庭与常规透析单元血压记录的比较
J Hum Hypertens. 2025 May;39(5):355-361. doi: 10.1038/s41371-025-01007-7. Epub 2025 Mar 17.
4
Day-to-day blood pressure variability in older persons - optimizing measurement.老年人日常血压变异性——优化测量
J Hypertens. 2025 Jun 1;43(6):970-975. doi: 10.1097/HJH.0000000000003975. Epub 2025 Feb 20.
5
Differences in ambulatory versus home blood pressure levels by ethnicity: data from the United Kingdom and Japan.不同种族人群动态血压与家庭血压水平的差异:来自英国和日本的数据。
J Hum Hypertens. 2024 Dec;38(12):828-835. doi: 10.1038/s41371-024-00962-x. Epub 2024 Sep 29.
6
Evaluating novel approaches for estimating awake and sleep blood pressure: design of the Better BP Study - a randomised, crossover trial.评估估计清醒和睡眠血压的新方法:更好的 BP 研究的设计 - 一项随机、交叉试验。
BMJ Open. 2022 Jun 6;12(6):e058140. doi: 10.1136/bmjopen-2021-058140.
7
A Novel Intensity-Based Approach to Increasing Prefrontal Cerebral Oxygenation by Walking Exercise.一种通过步行锻炼增加前额叶脑氧合的基于强度的新方法。
J Pers Med. 2022 Mar 22;12(4):510. doi: 10.3390/jpm12040510.
8
Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial.常服对乙酰氨基酚与高血压人群的血压:PATH-BP 试验。
Circulation. 2022 Feb 8;145(6):416-423. doi: 10.1161/CIRCULATIONAHA.121.056015. Epub 2022 Feb 7.
9
Day-To-Day Home Blood Pressure Variability and All-Cause Mortality in a Memory Clinic Population.日常家庭血压变异性与记忆门诊人群的全因死亡率。
J Alzheimers Dis. 2022;85(3):1219-1231. doi: 10.3233/JAD-215002.
10
Cardiovascular risk factors of airport visitors in India: results from a nation-wide campaign.印度机场访客的心血管危险因素:一项全国性运动的结果。
J Clin Hypertens (Greenwich). 2022 Jan;24(1):74-82. doi: 10.1111/jch.14413. Epub 2021 Dec 13.